New healthcare reform in a new era Challenges for multinational pharmaceutical companies and corresponding countermeasures to be taken

New Healthcare Reform in a New Era: Challenges for Multinational Pharmaceutical Companies and Corresponding Countermeasures to be Taken is a series of articles on multinational pharmaceutical companies (MPCs) developed by Deloitte Research. As the healthcare reform progresses, MPCs are facing an increasingly challenging environment. For MPCs, if they achieve to adapt to China’s policies and market trends and reconstruct their strategies accordingly, they will still be able to seize market opportunities and develop new competitive advantages.